Good News: Covaxin Shows 78% Efficacy In Phase 3 Interim Analysis
Hyderabad: For those who are still a tad hesitant in taking the Covaxin jab, there’s reassuring news.
The phase 3 interim analysis of the Bharat Biotech-manufactured coronavirus vaccine…